Platinum-sensitive Relapsed Ovarian Cancer

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2023-04-13
Clinical Trial Update: Clinical Trial Evaluating the Efficacy and Safety of ZL-2306 (Niraparib) in Ovarian Cancer Patient [Phase 3]
A Phase 3 clinical trial evaluating the efficacy and safety of ZL-2306 (niraparib) in platinum-sensitive relapsed ovarian cancer is ongoing,…